🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Lund University Hospital
Start Date
1996-04
Trial ID
NCT00002764
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Status
Active Not Recruiting
Location
Regional Medical Center
Start Date
2003-11
Trial ID
NCT00070564
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of Bendamu...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-04-23
Trial ID
NCT00916058
Treatments Being Tested
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
Site Reference ID/Investigator# 17841
Start Date
2009-11
Trial ID
NCT00868413
This phase I trial studies the side effects and best dose of ADH-1 when giv...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2013-04-09
Trial ID
NCT01825603
Treatments Being Tested
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Status
Completed
Location
Cancer Research Campaign Trials Unit-Birmingham (CRCTU)
Start Date
1993-06
Trial ID
NCT00002582
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720